AAAAAA
Results:
1-17
|
Results: 17
Authors:
Meyer, T
Cole, LA
Richman, PI
Mitchell, HDC
Myers, J
Rustin, GJS
Citation: T. Meyer et al., High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men, CL ONCOL-UK, 13(4), 2001, pp. 301-303
Authors:
Rustin, GJS
Marples, M
Nelstrop, AE
Mahmoudi, M
Meyer, T
Citation: Gjs. Rustin et al., Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels, J CL ONCOL, 19(20), 2001, pp. 4054-4057
Authors:
Vergote, I
Rustin, GJS
Eisenhauer, EA
Kristensen, GB
Pujade-Lauraine, E
Parmar, MKB
Friedlander, M
Jakobsen, A
Vermorken, JB
Citation: I. Vergote et al., Re: New guidelines to evaluate the response to treatment in solid tumors [ovarian cancer], J NAT CANC, 92(18), 2000, pp. 1534-1535
Authors:
Napier, MP
Rustin, GJS
Citation: Mp. Napier et Gjs. Rustin, Diagnostic delay and risk of relapse in patients with stage I nonseminomatous germ cell tumour followed on active surveillance, BJU INT, 86(4), 2000, pp. 486-489
Authors:
Francis, R
Bower, M
Brunstrom, G
Holden, L
Newlands, ES
Rustin, GJS
Seckl, MJ
Citation: R. Francis et al., Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options, EUR J CANC, 36(15), 2000, pp. 1925-1932
Authors:
Rustin, GJS
Nelstrop, AE
Bentzen, SM
Bond, SJ
McClean, P
Citation: Gjs. Rustin et al., Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials, J CL ONCOL, 18(8), 2000, pp. 1733-1739
Authors:
Newlands, ES
Mulholland, PJ
Holden, L
Seckl, MJ
Rustin, GJS
Citation: Es. Newlands et al., Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors, J CL ONCOL, 18(4), 2000, pp. 854-859
Authors:
Tuxen, MK
Soletormos, G
Rustin, GJS
Nelstrop, AE
Dombernowsky, P
Citation: Mk. Tuxen et al., Biological variation and analytical imprecision of CA 125 in patients withovarian cancer, SC J CL INV, 60(8), 2000, pp. 713-721
Authors:
Napier, MP
Naraghi, A
Christmas, TJ
Rustin, GJS
Citation: Mp. Napier et al., Long-term follow-up of residual masses after chemotherapy in patients withnon-seminomatous germ cell tumours, BR J CANC, 83(10), 2000, pp. 1274-1280
Authors:
Meyer, T
Rustin, GJS
Citation: T. Meyer et Gjs. Rustin, Role of tumour markers in monitoring epithelial ovarian cancer, BR J CANC, 82(9), 2000, pp. 1535-1538
Authors:
Lee, CK
de Miranda, MP
Ledermann, JA
de Elvira, MCR
Nelstrop, AE
Lambert, HE
Rustin, GJS
Trask, CWL
Citation: Ck. Lee et al., Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy, EUR J CANC, 35(5), 1999, pp. 727-732
Authors:
Bertelsen, K
Grenman, S
Rustin, GJS
Citation: K. Bertelsen et al., How long should first-line chemotherapy continue?, ANN ONCOL, 10, 1999, pp. 17-20
Authors:
Rustin, GJS
Nelstrop, AE
Bentzen, SM
Piccart, MJ
Bertelsen, K
Citation: Gjs. Rustin et al., Use of tumour markers in monitoring the course of ovarian cancer, ANN ONCOL, 10, 1999, pp. 21-27
Authors:
Berek, JS
Bertelsen, K
du Bois, A
Brady, MF
Carmichael, J
Eisenhauer, EA
Gore, M
Grenman, S
Hamilton, TC
Hansen, SW
Harper, PG
Horvath, G
Kaye, SB
Luck, HJ
Lund, B
McGuire, WP
Neijt, JP
Ozols, RF
Parmar, MKB
Piccart-Gebhart, MJ
van Rijswijk, R
Rosenberg, P
Rustin, GJS
Sessa, C
Thigpen, JT
Trope, C
Tuxen, MK
Vergote, I
Vermorken, JB
Willemse, PHB
Citation: Js. Berek et al., Advanced epithelial ovarian cancer: 1998 consensus statements, ANN ONCOL, 10, 1999, pp. 87-92
Authors:
Bridgewater, JA
Nelstrop, AE
Rustin, GJS
Gore, ME
McGuire, WP
Hoskins, WJ
Citation: Ja. Bridgewater et al., Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel, J CL ONCOL, 17(2), 1999, pp. 501-508
Authors:
Bridgewater, JA
Rustin, GJS
Citation: Ja. Bridgewater et Gjs. Rustin, Management of non-epithelial ovarian tumours, ONCOL-BASEL, 57(2), 1999, pp. 89-98
Authors:
Fossa, SD
Stenning, SP
Gerl, A
Horwich, A
Clark, PI
Wilkinson, PM
Jones, WG
Williams, MV
Oliver, RT
Newlands, ES
Mead, GM
Cullen, MH
Kaye, SB
Rustin, GJS
Cook, PA
Citation: Sd. Fossa et al., Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours, BR J CANC, 80(9), 1999, pp. 1392-1399
Risultati:
1-17
|